Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned an average recommendation of “Moderate Buy” from the twenty-nine brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation, nineteen have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month target price among analysts that have covered the stock in the last year is $608.9231.

Several research analysts recently issued reports on ISRG shares. Evercore ISI increased their target price on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Leerink Partners raised their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Hsbc Global Res raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Finally, The Goldman Sachs Group lifted their target price on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $538.82 on Wednesday. The firm’s fifty day moving average is $467.13 and its 200-day moving average is $499.56. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a market cap of $193.15 billion, a P/E ratio of 71.27, a P/E/G ratio of 4.94 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the firm posted $1.84 EPS. The company’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 2,193 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $548.01, for a total value of $1,201,785.93. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of the business’s stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at approximately $193,595.79. This represents a 95.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 96,011 shares of company stock valued at $50,309,042 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Brighton Jones LLC lifted its holdings in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares during the last quarter. Golden State Wealth Management LLC boosted its position in shares of Intuitive Surgical by 13.7% during the first quarter. Golden State Wealth Management LLC now owns 1,757 shares of the medical equipment provider’s stock valued at $870,000 after purchasing an additional 212 shares in the last quarter. Sovran Advisors LLC increased its stake in shares of Intuitive Surgical by 58.2% in the 1st quarter. Sovran Advisors LLC now owns 734 shares of the medical equipment provider’s stock worth $354,000 after acquiring an additional 270 shares in the last quarter. Avidian Wealth Enterprises LLC increased its stake in shares of Intuitive Surgical by 9.7% in the 1st quarter. Avidian Wealth Enterprises LLC now owns 988 shares of the medical equipment provider’s stock worth $489,000 after acquiring an additional 87 shares in the last quarter. Finally, Ameritas Advisory Services LLC increased its stake in shares of Intuitive Surgical by 5.9% in the 1st quarter. Ameritas Advisory Services LLC now owns 1,724 shares of the medical equipment provider’s stock worth $878,000 after acquiring an additional 96 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.